This was interesting because at that time it was assumed that the best way to treat patients with metabolic disorders was not to stimulate more glucagon because it raises blood sugar, but instead to block it
Once the treatment is stopped, the effects are reversed fairly quickly
The bottom line : theres currently no evidence that GLP-1 agonists enhance actual athletic performance in humans, and there are plausible reasons to worry they could hinder performance by reducing muscle and interfering with fuelling (more on that below)
Injection Basics Where : Subcutaneousbelly fat (2 inches from navel), thigh, or upper arm When : Same day each week, any time of day
American diabetes association professional practice committee, ElSayed NA, McCoy RG, Aleppo G, Balapattabi K, Beverly EA, et al
Some costs may qualify for HSA or FSA reimbursement depending on your plan